ArticleBioinformatics (Oxford, England)2022
Deep kernel learning improves molecular fingerprint prediction from tandem mass spectra.
Article in Bioinformatics (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 16 citations in OpenAlex.
- Oral Cavity Antibacterial Discovery Pipeline Driven by Advanced Analytical Techniques.Molecules (Basel, Switzerland) · 2026Review
- ChemEmbed: a deep learning framework for metabolite identification using enhanced MS/MS data and multidimensional molecular embeddings.Briefings in bioinformatics · 2026Article
- Article
- Interpretable adenylation domain specificity prediction using protein language models.bioRxiv : the preprint server for biology · 2025Article
- TransExION: a transformer based explainable similarity metric for comparing IONS in tandem mass spectrometry.Journal of cheminformatics · 2024Article
- Chemprop: A Machine Learning Package for Chemical Property Prediction.Journal of chemical information and modeling · 2024Article
- Automated Composition Assessment of Natural Extracts: Untargeted Mass Spectrometry-Based Metabolite Profiling Integrating Semiquantitative Detection.Journal of agricultural and food chemistry · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
motivationUntargeted metabolomics experiments rely on spectral libraries for structure annotation, but these libraries are vastly incomplete; in silico methods search in structure databases, allowing us to overcome this limitation. The best-performing in silico methods use machine learning to predict a molecular fingerprint from tandem mass spectra, then use the predicted fingerprint to search in a molecular structure database. Predicted molecular fingerprints are also of great interest for compound class annotation, de novo structure elucidation, and other tasks. So far, kernel support vector machines are the best tool for fingerprint prediction. However, they cannot be trained on all publicly available reference spectra because their training time scales cubically with the number of training data.
resultsWe use the Nyström approximation to transform the kernel into a linear feature map. We evaluate two methods that use this feature map as input: a linear support vector machine and a deep neural network (DNN). For evaluation, we use a cross-validated dataset of 156 017 compounds and three independent datasets with 1734 compounds. We show that the combination of kernel method and DNN outperforms the kernel support vector machine, which is the current gold standard, as well as a DNN on tandem mass spectra on all evaluation datasets. AVAILABILITY AND IMPLEMENTATION: The deep kernel learning method for fingerprint prediction is part of the SIRIUS software, available at https://bio.informatik.uni-jena.de/software/sirius.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.